Exogenesis Corp.

Exogenesis Corp.

Exogenesis Corp.

Date Founded



20 Fortune Drive,Billerica, MA 01821

Type of Company


Employees (Worldwide)

11 - 50


Medical Products & Equipment
Hospitals & Patient Services
Holding Companies

Company Description

Exogenesis Corp. processes implantable medical devices and other medical products. It is engaged in development activities with a number of partners and is interested in exploring new applications for its technology in biomedical and non-medical applications with partners interested in improving the properties and performance of materials. The company was founded by Richard C. Svrluga in 2005 and is headquartered in Billeric, MA.

Contact Data
Trying to get in touch with decision makers at Exogenesis Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Applications Director

Director & Technical Director

Engineering Director

Director-Product Development

Director-Cell & Molecular Biology



Chief Executive Officer (Acting)

Board of Directors

Co-Founder at Thematic Capital Partners LLP

Director & Technical Director at Exogenesis Corp.

General Partner at Inflection Point Ventures

Paths to Exogenesis Corp.
Potential Connections via
Relationship Science
Exogenesis Corp.
Recent Transactions
Details Hidden

Exogenesis Corp. raised money in a private placement transaction

Details Hidden

Exogenesis Corp. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onExogenesis Corp. raised money in a private placement transaction

Details Hidden

The Venture Capital Fund of New England(VCFNE) makes equity investments in emerging, growth-oriented companies. The firm invests primarily in companies located in the New England region of the US but they may occasionally consider investments in companies located outside the northeastern US. They target early-stage companies with emphasis on technology-based companies and direct marketing-related companies. VCFNE may also consider seed or expansion-stage investments.Companies in which the firm invests should have sound management, a favorable external environment and a proprietary technology or operating model. Companies should also operate in a market that offers major growth opportunity but may initially be too small to attract significant competition from large, established companies. VCFNE prefers to invest in companies with cost-effective distribution channels and in companies operating in markets without excessive price sensitivity. The firm looks for technology-based companies that have produced advanced, enabling technology that can be maintained as a proprietary corporate asset through patent or trade secret protection.Initial investments average $1 million and range from less than $500,000 to $1.5 million. Final individual investment positions are often greater than $3 million. Most of the firm's investments are made jointly with other investors. VCFNE has been the lead or co-lead investor in about 75% of their investments to date.

Details Hidden

Inflection Point Ventures (IPV) specializes in investments in early-stage telecommunications, information technology and e-Commerce companies. The firm seeks to invest in companies that have the potential to generate rapid growth in revenue, profitability and shareholder value. They look for companies with technology that can fundamentally change markets. IPV seeks to invest in companies that can introduce new, high value-added products and services, upset the status quo and capture market leadership.IPV invests primarily in pre- and post-revenue companies that are seeking their first round of equity financing. The firm prefers to lead or co-lead their investments. Initial investments range from $500,000 to $2 million. Most of IPV's investments are made in companies located in the Mid-Atlantic and New England regions of the US. IPV typically participates on their portfolio companies' Boards of Directors.

Details Hidden

Viavi Solutions, Inc. engages in the provision of network test, monitoring, and assurance solutions for communications service providers, enterprises, network equipment manufacturers, government and avionics. It operates through the following segments: Network Enablement, Service Enablement, and Optical Security and Performance. The Network Enablement segment offers integrated portfolio of testing solutions that access the network to perform build-out and maintenance tasks. The Service Enablement segment covers solutions and services primarily for communication service providers, and enterprises that deliver and/or operate broadband and IP networks (fixed and mobile) supporting voice, video, and data services as well as a wide range of applications. The Optical Security and Performance segment leverages its core optical coating technologies and volume manufacturing capability to design, manufacture, and sell products targeting anti-counterfeiting, consumer and industrial, government, healthcare, and other markets. The company was founded in 1979 and is headquartered in San Jose, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Exogenesis Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Exogenesis Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Exogenesis Corp..